MedTrace Logo

IV Paracetamol, Dexketoprofen or Morphine for the Treatment of Low Back Pain

NCT01422291 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2011-08-23

No results posted yet for this study

Summary

This randomized, controlled trial evaluates the analgesic efficacy and safety of intravenous single-dose paracetamol, dexketoprofen and morphine for the treatment of low back pain.

Conditions

  • Low Back Pain

Interventions

DRUG

morphine

0.1mg/kg intravenous in 100 ml serum physiologic

DRUG

Dexketoprofen

50 mg

DRUG

Paracetamole

1 gr

DRUG

paracetamol

1 gr

Sponsors & Collaborators

  • Pamukkale University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-07-31
Completion
2011-07-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01422291 on ClinicalTrials.gov